Price $13.76 |
Market Cap
59.3M
|
Sector Health Care |
Div. Growth
-100.00%
|
|
P/E
-
|
P/B
6.06
|
P/S
203.49
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
24.9
|
Op. Cash Flow
3.1K
|
FCF
0.5
|
|
Op. Margin
-32.70%
|
Net Margin
-130.40%
|
ROE
-3.80%
|
ROI
-
|
|
ROA
-2.90%
|
EPS Growth
-173.10%
|
Current Ratio
-
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| CYANOTECH CORP (CYAN) | $2.10 | - | - | 13.1M | Strong Buy |
| Assertio Therapeutics Inc (ASRT) | $0.83 | - | - | 71.2M | Strong Buy |
| Qiagen NV (QGEN) | $43.02 | - | - | 9.62B | Strong Buy |
| Prestige Consumer Healthcare I (PBH) | $44.07 | - | - | 2.05B | Strong Buy |
| MTBC Inc (MTBC) | $6.33 | - | - | 76.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
